BioCentury
ARTICLE | Distillery Therapeutics

Hematology

September 27, 2017 6:17 PM UTC

Cell culture and patient sample studies suggest inhibiting HBA-MCS-R2 could help treat β-thalassemia. In patients, high levels of α-globin (HBA) are associated with disease severity. In human erythroi...